These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10792230)

  • 1. Systemic Hodgkin's lymphoma in a patient with Sézary syndrome.
    Scarisbrick JJ; Child F; Spittle M; Calonje E; Russell-Jones R
    Br J Dermatol; 2000 Apr; 142(4):771-5. PubMed ID: 10792230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary malignant neoplasms in 71 patients with Sézary syndrome.
    Scarisbrick JJ; Child FJ; Evans AV; Fraser-Andrews EA; Spittle M; Russell-Jones R
    Arch Dermatol; 1999 Nov; 135(11):1381-5. PubMed ID: 10566838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The onset of double metachronous neoplasms 29 years after the diagnosis of Hodgkin's disease].
    Bisi D; Federico M; Sarti M; Barbieri F; Curci G
    Minerva Med; 1989 May; 80(5):511-4. PubMed ID: 2747980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sézary syndrome after successful treatment of Hodgkin's disease.
    Büchner SA
    Arch Dermatol; 1981 Jan; 117(1):50-4. PubMed ID: 7458386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of mycosis fungoides and Hodgkin's disease].
    Souquet PJ; Mauduit G; Coiffier B; Thivolet J
    Ann Dermatol Venereol; 1984; 111(11):981-6. PubMed ID: 6524817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycosis fungoides associated with B-cell malignancies.
    Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
    Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric non-Hodgkin's lymphoma after successful treatment of Hodgkin's disease.
    Eridani S; Singh AK
    Oncology; 1986; 43(2):107-9. PubMed ID: 3754040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous Hodgkin's lymphoma.
    Mukesh M; Shuttleworth D; Murray P
    Clin Exp Dermatol; 2009 Dec; 34(8):e673-5. PubMed ID: 19817768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial.
    Hancock BW; Gregory WM; Cullen MH; Hudson GV; Burton A; Selby P; Maclennan KA; Jack A; Bessell EM; Smith P; Linch DC; ;
    Br J Cancer; 2001 May; 84(10):1293-300. PubMed ID: 11355937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
    Lichtman SM; Brody J; Kaplan MH; Susin M; Koduru P; Goh JC
    Leuk Lymphoma; 1993 Mar; 9(4-5):393-8. PubMed ID: 7688628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Sézary syndrome].
    Ferreira F; Correia TM; Callabro L; Andrade J
    Acta Med Port; 1998 Dec; 11(12):1135-9. PubMed ID: 10192992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atopic dermatitis-like pre-Sézary syndrome: role of immunosuppression.
    Sokołowska-Wojdyło M; Barańska-Rybak W; Cegielska A; Trzeciak M; Lugowska-Umer H; Gniadecki R
    Acta Derm Venereol; 2011 Sep; 91(5):574-7. PubMed ID: 21681350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained remission of Sézary syndrome.
    Bouwhuis SA; McEvoy MT; Davis MD
    Eur J Dermatol; 2002; 12(3):287-90. PubMed ID: 11978575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sezary syndrome in a patient with hairy cell leukemia in remission.
    Crump M; Sutton DM; Pantalony D
    Cancer; 1991 Aug; 68(4):829-33. PubMed ID: 1649686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Hodgkin's lymphoma under bexarotene treatment for Sézary syndrome and review of the literature.
    Sanli H; Akay BN; Ozcan M
    J Drugs Dermatol; 2010 Aug; 9(8):1014-6. PubMed ID: 20684154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity.
    Yoo EK; Cassin M; Lessin SR; Rook AH
    J Am Acad Dermatol; 2001 Aug; 45(2):208-16. PubMed ID: 11464181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell lymphoma following Hodgkin's disease.
    Gowitt GT; Chan WC; Brynes RK; Heffner LT
    Cancer; 1985 Sep; 56(5):1191-6. PubMed ID: 3874686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sézary syndrome and seronegative polyarthritis: treatment with extracorporeal photochemotherapy.
    Macheiner W; Jantschitsch C; Graninger W; Pálóczy K; Bálint G; Marschalkó M; Kainberger F; Breier F; Knobler RM
    J Am Acad Dermatol; 2003 Feb; 48(2):220-6. PubMed ID: 12582392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Simultaneous occurrence of transplantation glomerulopathy, malignant Hodgkin lymphoma and lip cancer in a patient under immunosuppressive treatment].
    Nemes B; Lázár N; Járay J
    Orv Hetil; 1994 Jun; 135(24):1309-12. PubMed ID: 8015827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal photopheresis and adjuvant aerosolized granulocyte-macrophage colony-stimulating factor for Sézary syndrome.
    Bouwhuis SA; Markovic SN; McEvoy MT; Pittelkow MR
    Mayo Clin Proc; 2002 Feb; 77(2):197-200. PubMed ID: 11838656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.